Figure 4From: Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125 Cytotoxic effects of AEZS-125 with and without pretreatment with LHRH agonist triptorelin, in LHRH- receptor positive TNBC cells MDA-MB-231 (c) and HCC 1806 (b) and LTK (-) (a) cells the last of which do not express receptors for LHRH. Back to article page